Ciprofloxacin (CIP), as an extensively used antibiotic, has been widely detected at a high level in the environment and has raised environmental pollution concerns. Thus, efficient and cost-effective methods for CIP degradation are highly desired. Biologically produced manganese oxides (BioMnO) offer a promising perspective for CIP degradation because of their catalytic reactivity and cost-effectiveness. However, the release of Mn(II) from BioMnO prevents the further oxidation of pollutants. As a consequence, continuous CIP degradation by BioMnO is not feasible. In this work, a manganese redox cycling system driven by Pseudomonas putida MnB-1 was constructed for continuous degradation of CIP. In such a system CIP was oxidized continuously and rapidly by re-oxidizing the formed Mn(II) to regenerate reactive BioMnO, which also protected the strain from CIP toxicity. CIP was degraded through N-dealkylation passway. No significant loss of BioMnO reactivity was observed in three-cycle CIP degradation process, suggesting the stability of this system. An overlooked intracellular BioMnO, which was involved in CIP degradation, was discovered in P. putida MnB-1. Moreover, the important role of Mn(III) in facilitating CIP removal in this system was also identified. This work provides useful information to better understand the degradation of antibiotic compounds mediated by microbes in environments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chemosphere.2018.07.117 | DOI Listing |
Environ Res
January 2025
Key Laboratory of Oasis Ecology of Education Ministry, College of Ecology and Environment, Xinjiang University, Urumqi 830017, P.R. China; Xinjiang Jinghe Observation and Research Station of Temperate Desert Ecosystem, Ministry of Education, Urumqi 830017, P.R. China.
Antibiotics and antibiotic resistance genes (ARGs) are severe refractory pollutants in water. However, the effect of an intermittent electrical stimulation on the removal of antibiotics and ARGs from saline wastewater remains unclear. An anaerobic-aerobic-coupled upflow bioelectrochemical reactors (AO-UBERs) was used to treat tetracycline (TC) and quinolone (QN) in saline wastewater.
View Article and Find Full Text PDFEnviron Sci Pollut Res Int
January 2025
Department of Environmental Health, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Cell Chem Biol
December 2024
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address:
Chemical inducers of proximity (CIPs) are molecules that recruit one protein to another and introduce new functionalities toward modulating protein states and activities. While CIP-mediated recruitment of E3 ligases is widely exploited for the development of degraders, other therapeutic modalities remain underexplored. We describe a non-degrader CIP-DNA-encoded library (CIP-DEL) that recruits FKBP12 to target proteins using non-traditional acyclic structures, with an emphasis on introducing stereochemically diverse and rigid connectors to attach the combinatorial library.
View Article and Find Full Text PDFJ Environ Manage
January 2025
Shaanxi Geology and Mining Hanzhong Geological Brigade Co., Ltd., Hanzhong, 723000, China.
In this study, the adsorption of aqueous Cu(Ⅱ), Fe(Ⅱ), and Co(Ⅱ) on biochars at diverse synthesized temperatures was evaluated. The optimal sample BC-800 achieved superior adsorption performance of Cu(Ⅱ), Fe(Ⅱ), and Co(Ⅱ) at 10-50 mg L initial concentration. Due to the larger surface area (349.
View Article and Find Full Text PDFCancer Immunol Immunother
January 2025
Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, 241 W 11th Ave, Suite 5000, Columbus, OH, 43201, USA.
Background: Checkpoint inhibitor pneumonitis (CIP) that develops following immune checkpoint inhibitor (ICI) treatment can be difficult to distinguish from other common etiologies of lung inflammation in cancer patients. Here, we evaluate the bronchoalveolar lavage fluid (BAL) for potential biomarkers specific to CIP.
Methods: We conducted a retrospective study of patients who underwent standard of care bronchoscopy to compare the cytokines of interest between patients with and without CIP and with and without immune-mediated pulmonary diseases.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!